Curatis N Ag

Curatis: Double-Digit Revenue Growth in 2025 and Major Milestones for Corticorelin Achieved

Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan

Curatis: FDA Minutes Confirm Positive Outcome of Meeting on 9. September 2025 – Corticorelin on Track for Phase 3

Curatis: Double-Digit Growth in Core Business and Development Milestone Achieved for C-PTBE-01

Curatis Expands Distribution Business With Phoenix Labs with up to CHF 5m Additional Annual Revenues